1. Volume 154, Issue 1, Pages 138-143 (July 2019)
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients? 
Federica Tomao, Lucia Musacchio, Federica Di Mauro, Serena Maria Boccia, Violante Di Donato, Antonella Giancotti, Giorgia Perniola, Innocenza Palaia, Ludovico Muzii, Pierluigi Benedetti Panici 
Gynecologic Oncology 
Volume 154, Issue 1, Pages (July 2019)
DOI: /j.ygyno
Copyright © 2019 The Authors Terms and Conditions

2. Fig. 1
Rates of anemia and neutropenia per cycle among OC patients underwent chemotherapy, according to BRCA mutational status.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2019 The Authors Terms and Conditions

3. Fig. 2
Rates of anemia and neutropenia in NACT patients per cycle, according to BRCA mutational status.
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2019 The Authors Terms and Conditions